期刊
JOURNAL OF IMMUNOLOGY
卷 174, 期 5, 页码 2476-2480出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.174.5.2476
关键词
-
类别
CTL are important in combating cancer and viruses. Therefore, triggering the complete potential of CTL effector functions by new vaccination strategies will not only improve prophylaxis of tumor or virus-related diseases, but also open opportunities for effective therapeutic immunizations. Using transcutaneous immunization, we show that epicutaneous (e.c.)(4) application of an ointment containing a CTL epitope and the TLR7 ligand imiquimod is highly effective in activating T cells in mice using TCR-transgenic CTL or in wild-type mice. Transcutaneous immunization-activated CTL mount a full-blown immune response against the target epitope characterized by proliferation, cytolytic activity, and the production of IFN-gamma that is completely restricted to the epitope used for vaccination. Our results obtained by simple e. c. application of an ointment, without further skin irritating procedures, provide the basis for the development Of new, easy to use vaccines against cancer or virus-associated diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据